WO2016008816A1 - Herbicidal pyridazinone derivatives - Google Patents

Abstract

The present invention relates to herbicidal benzyloxy-substituted phenyl-diones and benzyloxy susbstituted phenyl-dioxo-thiazinone derivatives of formula (I), as well as to processes and intermediates used for the preparation of such derivatives. The invention further extends to herbicidal compositions comprising such derivatives, as well as to the use of such compounds and compositions in controlling undesirable plant growth: in particular the use in controlling weeds, such as broad-leaved dicotyledonous weeds, in crops of useful plants.

Description

HERBICIDAL PYRIDAZINONE DERIVATIVES

The present invention relates to herbicidal benzyloxy-substituted phenyl- pyridazine-diones and benzyloxy susbstituted phenyl-pyridazinone derivatives of formula (I), as well as to processes and intermediates used for the preparation of such

derivatives. The invention further extends to herbicidal compositions comprising such derivatives, as well as to the use of such compounds and compositions in controlling undesirable plant growth: in particular the use in controlling weeds, such as broad- leaved dicotyledonous weeds, in crops of useful plants.

Herbicidal pyridazinones are known from WO2009/086041 . In addition, herbicidal 5/6 membered heterocyclyl-substituted pyridazinones are known from WO 201 1/045271. Whilst WO2013/160126 describes indolyl-pyridazinone derivatives, which exhibit herbicidal activity.

The present invention is based on the finding benzyloxy-substituted phenyl- pyridazine-diones and benzyloxy susbstituted phenyl-pyridazinone derivatives of formula (I), exhibit surprisingly good herbicidal activity.

Thus, in a first aspect there is provided a compound of formula (I)

(I), or a salt or N-oxide thereof, wherein R¹ is selected from the group consisting of Ci-C₄ alkyl, C₃-C₆cycloalkyl, C₃-C₆alkoxy, Ci-C₂ alkoxy-CrC₂ alkyl, C₂-C₄ alkenyl, C C₄ haloalkyl, cyano-Ci-C₄alkyl, C₂-C₄ haloalkenyl, C₂-C₄ alkynyl and C₂-C₄ haloalkynyl; R² is selected from the group consisting of hydrogen, halogen, cyano, CrC₆alkyl, CrC₆haloalkyl, CrC₆haloalkoxy, d- C₃haloalkoxy-Ci-C₃alkyl-, CrC₆alkoxy, Ci-C₃alkoxy-CrC₃alkyl, Ci-C₃alkoxy-Ci- C₃alkoxy-CrC₃alkyl-, C₃-C₆cycloalkyl, C₂-C₆ alkenyl, C₂-C₆ haloalkenyl, C₂-C₆ alkynyl, CrC₆hydroxyalkyl-, CrC₆alkylcarbonyl-, -S(0)_mCrC₆alkyl, amino, Ci-C₆alkylamino, C C₆dialkylamino, -C(CrC₃alkyl)=N-0-Ci-C₃alkyl and C₂-C₆ haloalkynyl; G is hydrogen, or C(0)R³; X and Y are each independently hydrogen, C C₃ alkyl, C C₃ alkoxy, C C₃haloalkyl, Ci-C₃haloalkoxy, or halogen; Z is C C₃ alkyl, C C₃ alkoxy, Ci-C₃haloalkyl, CrC₃haloalkoxy, or halogen; m is an integer of 0, 1 or 2; n is an integer of 0, 1 , 2, 3, 4, or 5; R³ is selected from the group consisting of CrC₆alkyl, CrC₆alkenyl, CrC₆alkynyl, CrC₆alkyl-S-, -NR⁴R⁵ and phenyl optionally substituted by one or more R⁶; R⁴ and R⁵ are independently selected from the group consisting of Ci-C₆ alkyl and Ci-C₆ alkoxy, or R⁴ and R⁵ together can form a morpholinyl ring; and, R⁶ is selected from the group consisting of halogen, cyano, nitro, CrC₃alkyl, d-C₃haloalky, CrC₃alkoxy and C C₃haloalkoxy.

Compounds of Formula (I) may contain asymmetric centres and may be present as a single enantiomer, pairs of enantiomers in any proportion or, where more than one asymmetric centre are present, contain diastereoisomers in all possible ratios. Typically one of the enantiomers has enhanced biological activity compared to the other possibilities.

Similarly, where there are di-substituted alkenes, these may be present in E or Z form or as mixtures of both in any proportion.

Furthermore, compounds of formula (I) may be in equilibrium with alternative tautomeric forms. For example, a compound of formula (l-i), i.e. a compound of formula (I) wherein R² is hydrogen and G is hydrogen, can be drawn in at least three tautomeric forms:

It should be appreciated that all tautomeric forms (single tautomer or mixtures thereof), racemic mixtures and single isomers are included within the scope of the present invention.

Each alkyl moiety either alone or as part of a larger group (such as alkoxy, alkylthio, alkoxycarbonyl, alkylcarbonyl, alkylaminocarbonyl, or dialkylaminocarbonyl, et a/.) may be straight-chained or branched. Typically, the alkyl is, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, ie f-butyl, n-pentyl, neopentyl, or n- hexyl. The alkyl groups are generally CrC₆alkyl groups (except where already defined more narrowly), but are preferably CrC₄alkyl or Ci-C₃alkyl groups, and, more preferably, are CrC₂alkyl groups (such as methyl). Alkenyl and alkynyl moieties can be in the form of straight or branched chains, and the alkenyl moieties, where appropriate, can be of either the (£)- or (Z)-configuration. The alkenyl or alkynyl moieties are typically C₂-C₄alkenyl or C₂-C₄alkynyl, more specifically vinyl, allyl, ethynyl, propargyl or prop-1-ynyl. Alkenyl and alkynyl moieties can contain one or more double and/or triple bonds in any combination; but preferably contain only one double bond (for alkenyl) or only one triple bond (for alkynyl).

Preferably, the term cycloalkyl refers to cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.

In the context of the present specification the term "aryl" preferably means phenyl. The term "heteroaryl" as used herein means an aromatic ring system containing at least one ring heteroatom and consists of a single ring. Preferably, single rings will contain 1 ,

2 or 3 ring heteroatoms selected independently from nitrogen, oxygen and sulfur.

Typically "heteroaryl" is furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, 1 ,2,3-triazolyl,

1 ,2,4-triazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1 ,2,4-oxadiazolyl,

1 ,3,4-oxadiazolyl, 1 ,2,5-oxadiazolyl, 1 ,2,3-thiadiazolyl, 1 ,2,4-thiadiazolyl,

1 ,3,4-thiadiazolyl, 1 ,2,5-thiadiazolyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl,

1 ,2,3-triazinyl, 1 ,2,4-triazinyl, or 1 ,3,5-triazinyl.

Heterocyclyl groups and heterocyclic rings (either alone or as part of a larger group, such as heterocyclyl-alkyl-) are ring systems containing at least one heteroatom and can be in mono- or bi-cyclic form. Preferably, heterocyclyl groups will contain up to two heteroatoms which will preferably be chosen from nitrogen, oxygen and sulfur.

Examples of heterocyclic groups include oxetanyl, thietanyl, azetidinyl and 7-oxa- bicyclo[2.2.1]hept-2-yl. Heterocyclyl groups containing a single oxygen atom as heteroatom are most preferred. The heterocyclyl groups are preferably 3- to 8- membered, more preferably 3- to 6-membered rings.

Halogen (or halo) encompasses fluorine, chlorine, bromine or iodine. The same correspondingly applies to halogen in the context of other definitions, such as haloalkyl or halophenyl.

Haloalkyl groups having a chain length of from 1 to 6 carbon atoms are, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1 ,1 - difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoroethyl and 2,2,2-trichloroethyl, heptafluoro- n-propyl and perfluoro-n-hexyl.

Alkoxy groups preferably have a chain length of from 1 to 6 carbon atoms. Alkoxy is, for example, methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, isobutoxy, sec- butoxy or tert-butoxy or a pentyloxy or hexyloxy isomer, preferably methoxy and ethoxy. It should also be appreciated that two alkoxy substituents may be present on the same carbon atom.

Haloalkoxy is, for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 1 ,1 ,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2,2- difluoroethoxy or 2,2,2-trichloroethoxy, preferably difluoromethoxy, 2-chloroethoxy or trifluoromethoxy.

CrC₆alkyl-S- (alkylthio) is, for example, methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio or tert-butylthio, preferably methylthio or ethylthio.

CrC₆alkyl-S(0)- (alkylsulfinyl) is, for example, methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl or tert- butylsulfinyl, preferably methylsulfinyl or ethylsulfinyl.

Ci-C₆alkyl-S(0)₂- (alkylsulfonyl) is, for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl or tert-butylsulfonyl, preferably methylsulfonyl or ethylsulfonyl.

The group Q

(Q) is referred to herein as the pyridazine dione/pyridazinone moiety, wherein B denotes the point of attachment to the rest of the molecule (i.e. to the optionally substituted benzyloxy-phenyl moiety).

The present invention also includes agronomically acceptable salts that the compounds of formula (I) may form with amines (for example ammonia, dimethylamine and triethylamine), alkali metal and alkaline earth metal bases or quaternary ammonium bases. Among the alkali metal and alkaline earth metal hydroxides, oxides, alkoxides and hydrogen carbonates and carbonates used as salt formers, emphasis is to be given to the hydroxides, alkoxides, oxides and carbonates of lithium, sodium, potassium, magnesium and calcium, but especially those of sodium, magnesium and calcium. The corresponding trimethylsulfonium salt may also be used. The compounds of formula (I) according to the invention also include hydrates which may be formed during the salt formation.

Preferred values of R¹, R², R³, R⁴, R⁵, R⁶, G, X, Y, Z, m and n are as set out below, and a compound of formula (I) according to the invention may comprise any combination of said values. The skilled man will appreciate that values for any specified set of embodiments may combined with values for any other set of embodiments where such combinations are not mutually exclusive.

Preferably R¹ is selected from the group consisting of methyl, ethyl, propyl (in particular n- or c-propyl), propargyl or Cihaloalkyl. More preferably R¹ is methyl, ethyl, cyclopropyl, propargyl or Cifluoroalkyl. More preferably still R¹ is methyl, ethyl, cyclopropyl or propargyl.

Preferably R² is selected from the group consisting of hydrogen, CrC₆alkyl, d- C₆haloalkyl, CrC₆alkoxy, Ci-C₃alkoxy-Ci-C₃alkyl, C₃-C₆cycloalkyl, C₂-C₆ alkenyl, C₂-C₆ haloalkenyl, C₂-C₆ alkynyl and C₂-C₆ haloalkynyl. More preferably R² is selected from the group consisting of methyl, ethyl, cyclopropyl, trifluoromethyl and methoxymethyl, more preferably still cyclopropyl, trifluoromethyl or methyl, most preferably cyclopropyl or methyl. In one set of embodiments of the present invention R² is hydrogen. In a further set of embodiments R² is cyclopropyl, in a third set of embodiments R² is methyl, and in a fourth set of embodiments R² is trifluoromethyl.

As described herein, G may be hydrogen or -C(0)-R³, and R³ is selected from the group consisting of CrC₆alkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, CrC₆alkyl-S-, C

C₆alkoxy, -NR⁴R⁵ and phenyl optionally substituted by one or more R⁶. As defined herein, R⁴ and R⁵ are independently selected from the group consisting of Ci-C₆ alkyl, Ci-C₆ alkoxy-; or they can together form a morpholinyl ring. Preferably R⁴ and R⁵ are each independently selected from the group consisting of methyl, ethyl, propyl, methoxy, ethoxy and propoxy. R⁶ is selected from the group consisting of halogen, cyano, nitro, CrC₃alkyl, Ci-C₃haloalkyl, Ci-C₃alkoxy and Ci-C₃haloalkoxy.

Preferably R³ is C C₄ alkyl, C₂-C₃alkenyl, C₂-C₃alkynyl,-C C₃alkoxy, or -NR⁴R⁵ wherein R⁴ and R⁵ together form a morpholinyl ring. More preferably R³ is isopropyl, t- butyl, methyl, ethyl, propargyl or methoxy.

In one set of embodiments G is hydrogen or -C(0)-R³, wherein R³ is C C₄ alkyl, C₂-C₃alkenyl, C₂-C₃alkynyl or -Ci-C₃alkoxy. In a further set of embodiments G is hydrogen or -C(0)-R^3, wherein R³ is isopropyl, i-butyl, methyl, ethyl, propargyl or methoxy. However, it is particularly preferred that G is hydrogen.

X is preferably hydrogen, halogen, or Cihaloalkyl, more preferably hydrogen, fluoro, chloro, bromo, or Cifluoroalkyl and more preferably still, hydrogen, fluoro, chloro or trifluoromethyl. In one set of embodiments it is preferred that X is ortho with respect to the pyridazinone/pyridazine-dione moiety (group Q). It is particularly preferred that X is fluoro, chloro or d-haloalkyl (in particular Cifluoroalkyl) and is ortho with respect to pyridazinone/pyridazine-dione moiety (group Q). Y is preferably hydrogen, C1-C3 alkyl, CrC₃haloalkyl, or halogen. More preferably Y is hydrogen, chloro, fluoro, or bromo.

In one set of embodiments it is preferred that Y is ortho with respect to the benzyloxy moiety. In a further set of embodiments, Y is para with respect to the pyridazinone/pyridazine-dione moiety (group Q).

It is particularly preferred that Y is ortho with respect to the benzyloxy moiety and is halogen, in particular chloro or fluoro; more preferably chloro.

As described herein, Z may be C1-C3 alkyl, C1-C3 alkoxy, Ci-C₃haloalkyl, d- C₃haloalkoxy, or halogen and n is an integer of 0, 1 , 2, 3, 4, or 5. Accordingly, the benzyl moiety of formula (I) may be represented as follows wherein p denotes the point of attachment to the remainder of the molecule via the ether link:

Preferably each Z radical is independently selected from halogen (in particular chloro), methyl, methoxy, and trifluoromethyl. More preferably each Z radical is independently halogen (in particular chloro) or methoxy.

It is preferred that n is 0, 1 , or 2. Where n is 1 , it is preferred that Z is para with respect to the methoxy linker (i.e. Z is at position Z³). Where n is 2, it is preferred that one substituent will be para and the other will be meta with respect to the methoxy linker (i.e. one Z radical will be at position Z² or Z⁴, and the other Z radical will be at position Z³).

In one particularly preferred set of embodiments n is 0 (i.e. positions Z¹, Z², Z³, Z⁴ and Z⁵ all carry hydrogen).

In a further particularly preferred set of embodiments n is 2, and each Z is independently halogen, preferably each Z is chloro.

In a further particularly preferred set of embodiments, n is 1 , Z is para with respect to the methoxy linker and is methoxy (i.e. Z³ is methoxy, Z¹, Z², Z⁴, and Z⁵ all carry hydrogen.).

Table 1 below provides 87 specific examples of compounds of formula (I) of the invention. T of the present invention.

In the above structure the numbering system used to denote the position of X and Y is shown for the purposes of clarity only.

Compound R¹ X Y [Z N MR data

1.001 Me Me 6-CI 3-CI (CDCI3) 2.22 (3H, s), 3.66

(3H, s), 4.70 (1H, d), 5.08 (1H, d), 7.13-7.17 (2H, m), 7.24-7.30 (4H, m), 7.41 (1H, d).

1.002 Me Me (CDCI3) 7.58 (dd, 1H),

7.47-7.28 (m, 6H), 7.18- 7.09 (m, 2H), 6.75 (br. s., 1H), 5.13 (s, 2H), 3.76 (s, 3H), 2.29 (s, 3H).

1.003 Me Me 3-CI (CDCI3) 7.59 (br. s., 1H),

7.51 (dd, 1H), 7.46 (dd, 1H), 7.30-7.21 (m, 2H), 7.22-7.11 (m, 3H), 5.17- 4.62 (m, 2H), 3.67 (s, 3H), 2.19 (s, 3H).

1.004 Me Me 6-F 3-CI (CDCI3) 7.50 (dd, 1H), 7.30

(dd, 3H), 7.22-7.13 (m, 2H), 7.01 (t, 1H), 6.47 (br. s., 1H), 5.18 (d, 1H), 4.68 (d, 1H), 3.72 (s, 3H), 2.23 (s, 3H).

1.005 Me Me 6-CI 3-CI 3,4-di CI (CDCI3) 7.38 (d, 1H), 7.33

(d, 1H), 7.24-7.18 (m, 2H), 6.97 (dd, 1H), 5.00 (d, 1H), 4.64 (d, 1H), 3.61 (s, 3H), 2.23 (s, 3H). Compound R X Y [Z]„ N MR data

1.006 Me Me 6-CI 4-CI (CDCI3) 7.36-7.24 (m, 5H),

7.15 (d, 1H), 6.92 (d, 1H), 5.99 (br. s., 1H), 6.05-5.87 (m, 1H), 5.00 (s, 2H), 3.70 (s, 3H), 2.29 (s, 3H).

1.007 Me Et 6-CI 3-CI (CDCI3) 7.36 (d, 1H), 7.27- 7.24 (m, 3H), 7.18 (d, 1H), 7.13 (dd, 2H), 5.03 (d, 1H), 4.66 (d, 1H), 3.63 (s, 3H), 2.58 (q, 2H), 1.16 (t, 3H).

1.008 CF₃ Me 6-CI 3-CI -

1.009 Me cyclopropyl 6-CI 3-CI (400 MHz, DMSO-d6): 10.8

(bs, 1H), 7.61 (d, J=8.8, 1H), 7.41 (d, J=8.8, 1H), 7.30-7.29 (m, 3H), 7.1 (s, 2H), 4.86 (d, J=10.96, 1H), 4.74 (d, J=10.92, 1H), 3.48 (s, 3H), 2.12 (t, 1H), 0.89- 0.68 (m,4H).

1.010 Me Et 6-F 3-CI (400 MHz, DMSO-d6):

10.75 (s, 1H), 7.63-7.60 (m, 1H), 7.29-7.28 (m, 3H), 7.18-7.13 (m, 3H), 4.89 (d, J=11, 1H), 4.71 (d, J=10.9, 1H), 3.53 (s, 3H), 2.59-2.50 (m, 2H), 1.11 (t, J=7.4, 3H).

1.011 CF₃ Me 6-F 3-CI -

1.012 Me cyclopropyl 6-F 3-CI (400 MHz, DMSO-d6):

10.86 (s, 1H), 7.64-7.60 (m, 1H), 7.30-7.29 (m, 3H), 7.19-7.14 (m, 3H), 4.89 (d, J=10.9, 1H), 4.72 (d, J=11, 1H), 3.48 (s, 3H), 2.12 (t, J=5.1, 1H), 0.89-0.71 (m, 4H).

1.013 Me Me 6-CI 3-CI 4-CI

1.014 Me Me 6-CI 3-F (400MHz, CDCI3) δ = 7.36

-7.27 (m, 3H), 7.25-7.15 (m, 4H), 5.51 (br. s., 1H), 5.18 - 5.14 (m, 1H), 4.98 (d, J=11.1 Hz, 1H), 3.71 (s, 3H), 2.27 (s, 3H).

1.015 Me Me - 3-F - Compound R R' X Y [Z]„ N MR data

1.016 Me Me 6-F 3-F (400 MHz, CDCI3) δ = 7.31

- 7.27 (m, 3H), 7.23 - 7.16 (m, 3H), 6.92 (dt, J=3.8, 8.8 Hz, 1 H), 6.19 (br. s., 1 H), 5.21 (d, J=1 1.0 Hz, 1 H), 4.93 (d, J=1 1.1 Hz, 1 H), 3.71 (s, 3H), 2.25 (s, 3H).

1.017 Me Me 6-CI 3-F 3,4-di CI

1.018 Me Me 6-CI 4-F -

1.019 Me Et 6-CI 3-F -

1.020 CF₃ Me 6-CI 3-F -

1.021 Me cyclopropyl 6-CI 3-F -

1.022 Me Et 6-F 3-F -

1.023 CF₃ Me 6-F 3-F -

1.024 Me cyclopropyl 6-F 3-F -

1.025 Me Me 6-CI 3-F 4-CI

1.026 Me Me 6-CI 3-Br -

1.027 Me Me 6-Br 3-Br -

1.028 Me Me - 3-Br -

1.029 Me Me 6-F 3-Br -

1.030 Me Me 6-CI 3-Br 3,4-di CI

1.031 Me Me 6-CI 4-Br -

1.032 Me Et 6-CI 3-Br -

1.033 Me Me 6-CI 3-Br 4-CI

1.034 Et Me 6-CI 3-CI -

1.035 Et Me - - -

1.036 Et Me - 3-CI -

1.037 Et Me 6-F 3-CI (400 MHz, CDCI3) δ ppm:

1.01 - 1.16 (m, 1 H) 1.30 (t, J=7.15 Hz, 3 H) 2.18 (s, 3 H) 4.02 - 4.17 (m, 2 H) 4.59 - 4.69 (m, 1 H) 5.06 - 5.16 (m, 1 H) 6.89 (s, 1 H) 7.1 1 - 7.17 (m, 2 H) 7.23 - 7.29 (m, 3 H) 7.36 - 7.43 (m, 1 H)

1.038 Et Me 6-CI 3-CI 3,4-di CI

1.039 Et Me 6-CI 4-CI -

1.040 Et Et 6-CI 3-CI - Compound R R' X Y [Z]„ N MR data

1.041 cyclopropyl Me 6-CI 3-CI (400 MHz, CDCI3) δ = 7.41

(d, 1 H), 7.22-7.29 (m, 4H), 7.1 1-7.17 (m, 2H), 5.06 (d, 1 H), 4.71 (d, 1 H), 3.97 (m, 1 H), 2.18 (s, 3H), 0.91-1.12 (m, 4H).

1.042 Et cyclopropyl 6-CI 3-CI -

1.043 Et Et 6-F 3-CI -

1.044 cyclopropyl Me 6-F 3-CI (400 MHz, CDCI3) δ = 7.42

(dd, 1 H), 7.30-7.22 (m, 3H), 7.19-7.13 (m, 2H), 6.93 (t, 1 H), 5.10 (d, 1 H), 4.68 (d, 1 H), 3.95 (m, 1 H), 2.16 (s, 3H), 1.1 1-0.89 (m, 4H).

1.045 Et cyclopropyl 6-F 3-CI -

1.046 Et Me 6-CI 3-CI 4-CI

1.047 Et Me 6-CI 3-F -

1.048 Et Me - 3-F -

1.049 Et Me 6-F 3-F -

1.050 Et Me 6-CI 3-F 3,4-di CI

1.051 Et Me 6-CI 4-F -

1.052 Et Et 6-CI 3-F -

1.053 cyclopropyl Me 6-CI 3-F -

1.054 Et cyclopropyl 6-CI 3-F -

1.055 Et Et 6-F 3-F -

1.056 cyclopropyl Me 6-F 3-F -

1.057 Et cyclopropyl 6-F 3-F -

1.058 Et Me 6-CI 3-F 4-CI

1.059 Et Me 6-CI 3-Br -

1.060 Et Me 6-Br 3-Br -

1.061 Et Me - 3-Br -

1.062 Et Me 6-F 3-Br -

1.063 Et Me 6-CI 3-Br 3,4-di CI

1.064 Et Me 6-CI 4-Br -

1.065 Et Et 6-CI 3-Br -

1.066 Et Me 6-CI 3-Br 4-CI Compound R X Y [Z]„ N MR data

1.067 Me Me 6-CI 3-CI 4-OMe (400 MHz, CDCI3): δΗ:

7.44 (d, J = 8.7, 1H), 7.26 (d, J = 8.7, 1H), 7.10-7.03 (m, 2H), 6.82-6.76 (m, 2H), 6.02 (br. s., 1H), 5.03 (d, J = 10.6, 1H), 4.66 (d, J = 10.6, 1H), 3.80 (s, 3H), 3.72 (s, 3H), 2.25 (s, 3H).

1.068 Me Me 6-CI (400 MHz, DMSO-d6): δΗ:

7.44-7.24 (m, 5H), 7.22- 6.96 (m, 2H), 5.15-5.02 (m, 2H), 3.56 (s, 3H), 2.21 (s, 3H).

1.069 Me Me 6-CF₃ 3-F (400 MHz, CDCI3) δ = 7.51

(dd, J=4.5, 8.8 Hz, 1H), 7.35-7.27 (m, 4H), 7.20- 7.14 (m,2H), 5.37-5.30 (br. s., 1H), 5.18 - 5.12 (m, 1H), 5.00 (d, J=11.1 Hz, 1H), 3.67 (s, 3H), 2.24 (s, 3H).

1.070 Me cyclopropyl 6-CF3 3-CI (400 MHz, DMSO-d6):

10.83 (s, 1H), 7.83 (d, J=8.5, 1H), 7.65 (d, J=8.5, 1H), 7.30-7.29 (m, 3H), 7.09 (s, 2H), 4.9 (d, J=10.8, 1H), 4.81 (d, J=10.9, 1H), 3.44 (s, 3H), 2.11 (t, J=6, 1H), 0.88-0.63 (m, 4H).

1.071 Me CF₃ 6-CF3 3-CI (400 MHz, DMSO-d6): 12.1

(bs, 1H), 7.87 (d, J=8.4, 1H), 7.67 (d, J=8.6, 1H), 7.3-7.29 (m, 3H), 7.13-7.12 (m, 2H), 4.99 (d, J=11.4, 1H), 4.79 (d, J=11.4, 1H), 3.54 (s, 3H). Compound R¹ X Y [Z]„ NMR data

1.072 Me Et 6-CF3 3-CI (400 MHz, DMSO-d6):

10.72 (s, 1H), 7.82 (d, J=8.48, 1H), 7.64 (d, J=8.6, 1H), 7.3-7.29 (m, 3H), 7.1- 7.09 (m, 2H), 4.9 (d, J=11.04, 1H), 4.82 (d, J=11.04, 1H), 3.49 (s, 3H), 2.57-2.5 (m, 2H), 1.08 (t, J=7.4, 3H).

1.073 Me Me 6-CF3 3-CI (400 MHz, CDCI3): 10.73

(s, 1H), 7.82 (d, J=8.5, 1H), 7.64 (d, J=8.5, 1H), 7.32- 7.3 (m, 3H), 7.13-7.11 (m, 2H), 4.91-4.82 (m, 2H), 3.49 (s, 3H), 2.14 (s, 3H).

1.074 Me CF₃ 6-F 3-CI (400 MHz, DMSO-d6):12.1

(bs, 1H), 7.69-7.65 (m, 1H), 7.28-7.27 (m, 3H), 7.21-7.15 (m, 3H), 4.97 (d, J=11.3, 1H), 4.7 (d, J=11.3, 1H), 3.58 (s, 3H).

1.075 Me CF₃ 6-CI 3-CI (400 MHz, CDCI3): 7.65 (d,

J=8.72, 1H), 7.43 (d, J=8.72, 1H), 7.29-7.27 (m, 3H), 7.14-7.13 (m, 2H), 4.92-4.73 (m, 2H), 3.58 (s, 3H).

1.076 Me Me 6-Me 3-CI (400 MHz, CDCI3) δ = 7.41

(d, J=8.3 Hz, 1H), 7.30- 7.27 (m, 3H), 7.18-7.13 (m, 2H), 7.09 (d, J=8.7 Hz, 1H), 5.70 (br. s., 1H), 5.09 (d, J=11.0 Hz, 1H), 4.62 (d, J=11.0 Hz, 1H), 3.70 (s, 3H), 2.23 (s, 3H), 2.13 (s, 3H). Compound R R' X Y [Z]„ N MR data

1.077 -CH₂C≡CH Me 6-F 3-CI (400 MHz, MeCN-d3) δ

ppm: 7.38 - 7.48 (m, 1 H), 7.24 - 7.36 (m, 5 H), 6.87 (s, 1 H), 4.80 (s, 2 H), 4.70 (dd, J=12.04, 2.38 Hz, 2 H), 3.91 - 4.18 (m, 1 H), 2.45 - 2.46 (m, 1 H), 2.04 (s, 3 H).

1.078 Me NH₂ 6-F 3-CI -

1.079 Me -S0₂Me 6-F 3-CI -

1.080 Me -S(0)Me 6-F 3-CI -

1.081 Me NH₂ 6-CI 3-CI -

1.082 Me -S0₂Me 6-CI 3-CI -

1.083 Me -S(0)Me 6-CI 3-CI -

1.084 Me -SMe 6-F 3-CI -

1.085 Me NMe₂ 6-F 3-CI -

1.086 Me -SMe 6-CI 3-CI -

1.087 Me NMe₂ 6-CI 3-CI -

The compounds of the present invention may be prepared according to the following schemes, in which the substituents R¹, R², R³, R⁴, R⁵, R⁶, G, X, Y, Z, m and n have (unless otherwise stated explicitly) the definitions described hereinbefore.

Certain compounds (1 ) of the present invention may be prepared from compounds of formula (2) as shown in Reaction scheme 1.

Reaction scheme 1

Compounds of formula (1 ) may be prepared by treatment of ester compounds (2) with 1 ,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) in acetonitrile solvent, at a temperature between 100 and 150 °C. Microwave heating or conventional heating may be used.

Compounds of formula (2) may be prepared from compounds of formulae (3) & (4) as shown in Reaction scheme 2. Reaction scheme 2

Compounds of formula (2) may be prepared by /V-acylation of hydrazones (4) with the acyl chloride derivative of compounds (3), in the presence of a suitable base and solvent, at a temperature between 0 and 25 °C. The acyl chloride is pre-formed by treatment of acids (3) with oxalyl chloride in a suitable solvent, optionally with inclusion of /V,/V-dimethylformamide as a catalyst, at a temperature between 0 and 50 °C. Examples of suitable bases are triethylamine or diisopropylethylamine. Examples of suitable solvents are dichloromethane and chloroform.

Compounds of formula (4) may be prepared by condensation of α-keto esters with hydrazines as shown in Reaction scheme 3.

Reaction scheme 3

Compounds of formula (3) may be prepared by oxidation of olefins (5) according to Reaction scheme 4.

Reaction scheme 4

NaCIC-2

Certain olefin compounds (5), specifically subset (5a), may be prepared by the O-alkylation of 2-allyl-phenols (6) with a benzyl halide compound, as shown in Reaction scheme 5.

Reaction scheme 5

J = H, halogen or Ci.C₂haloalkyl

E = halogen

X = halogen

With reference to Reaction scheme 5, many benzyl halides are commercially available. An example is benzyl bromide. 2-allyl-phenols (6) may be prepared as shown in Reaction scheme 6. Reaction scheme 6

J = H, halogen or Ci.C₂haloalkyl

E = halogen

With reference to Reaction scheme 6, an example of compounds (7) is 2-allyloxy-1 ,4 dichloro-benzene, prepared according to J. Chem. Soc, Perkin Trans. 2, 2001 , 1824 Other compounds (7) may be synthesised similarly, according to Reaction scheme 7.

J = H, halogen or Ci.C₂haloalkyl

E = halogen

With reference to Reaction scheme 7, many phenol compounds (8) are commercially available. Examples include 2,5-dichlorophenol and 2-chloro-5- fluorophenol.

The compounds of Formula (I) according to the invention can be used as herbicides by themselves, but they are generally formulated into herbicidal compositions using formulation adjuvants, such as carriers, solvents and surface-active agents (SFAs). Thus, the present invention further provides a herbicidal composition comprising a herbicidal compound according to any one of the previous claims and an agriculturally acceptable formulation adjuvant. The composition can be in the form of concentrates which are diluted prior to use, although ready-to-use compositions can also be made. The final dilution is usually made with water, but can be made instead of, or in addition to, water, with, for example, liquid fertilisers, micronutrients, biological organisms, oil or solvents.

The herbicidal compositions generally comprise from 0.1 to 99 % by weight, especially from 0.1 to 95 % by weight, compounds of Formula I and from 1 to 99.9 % by weight of a formulation adjuvant which preferably includes from 0 to 25 % by weight of a surface-active substance.

The compositions can be chosen from a number of formulation types, many of which are known from the Manual on Development and Use of FAO Specifications for Plant Protection Products, 5th Edition, 1999. These include dustable powders (DP), soluble powders (SP), water soluble granules (SG), water dispersible granules (WG), wettable powders (WP), granules (GR) (slow or fast release), soluble concentrates (SL), oil miscible liquids (OL), ultra low volume liquids (UL), emulsifiable concentrates (EC), dispersible concentrates (DC), emulsions (both oil in water (EW) and water in oil (EO)), micro-emulsions (ME), suspension concentrates (SC), aerosols, capsule suspensions (CS) and seed treatment formulations. The formulation type chosen in any instance will depend upon the particular purpose envisaged and the physical, chemical and biological properties of the compound of Formula (I).

Dustable powders (DP) may be prepared by mixing a compound of Formula (I) with one or more solid diluents (for example natural clays, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulphur, lime, flours, talc and other organic and inorganic solid carriers) and mechanically grinding the mixture to a fine powder. Soluble powders (SP) may be prepared by mixing a compound of Formula (I) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulphate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water soluble granules (SG).

Wettable powders (WP) may be prepared by mixing a compound of Formula (I) with one or more solid diluents or carriers, one or more wetting agents and, preferably, one or more dispersing agents and, optionally, one or more suspending agents to facilitate the dispersion in liquids. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water dispersible granules (WG).

Granules (GR) may be formed either by granulating a mixture of a compound of Formula (I) and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of Formula (I) (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller's earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of Formula (I) (or a solution thereof, in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulphates or phosphates) and drying if necessary. Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils). One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent).

Dispersible Concentrates (DC) may be prepared by dissolving a compound of

Formula (I) in water or an organic solvent, such as a ketone, alcohol or glycol ether. These solutions may contain a surface active agent (for example to improve water dilution or prevent crystallisation in a spray tank).

Emulsifiable concentrates (EC) or oil-in-water emulsions (EW) may be prepared by dissolving a compound of Formula (I) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or methylcyclohexanone) and alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkylpyrrolidones (such as N-methylpyrrolidone or N- octylpyrrolidone), dimethyl amides of fatty acids (such as C₈-Ci₀ fatty acid dimethylamide) and chlorinated hydrocarbons. An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment.

Preparation of an EW involves obtaining a compound of Formula (I) either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70°C) or in solution (by dissolving it in an appropriate solvent) and then emulsifying the resultant liquid or solution into water containing one or more SFAs, under high shear, to produce an emulsion. Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents which have a low solubility in water.

Microemulsions (ME) may be prepared by mixing water with a blend of one or more solvents with one or more SFAs, to produce spontaneously a thermodynamically stable isotropic liquid formulation. A compound of Formula (I) is present initially in either the water or the solvent SFA blend. Suitable solvents for use in MEs include those hereinbefore described for use in in ECs or in EWs. An ME may be either an oil-in- water or a water-in-oil system (which system is present may be determined by conductivity measurements) and may be suitable for mixing water-soluble and oil- soluble pesticides in the same formulation. An ME is suitable for dilution into water, either remaining as a microemulsion or forming a conventional oil-in-water emulsion.

Suspension concentrates (SC) may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of Formula (I). SCs may be prepared by ball or bead milling the solid compound of Formula (I) in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle. Alternatively, a compound of Formula (I) may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product.

Aerosol formulations comprise a compound of Formula (I) and a suitable propellant (for example n-butane). A compound of Formula (I) may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n- propanol) to provide compositions for use in non-pressurised, hand-actuated spray pumps. Capsule suspensions (CS) may be prepared in a manner similar to the preparation of EW formulations but with an additional polymerisation stage such that an aqueous dispersion of oil droplets is obtained, in which each oil droplet is encapsulated by a polymeric shell and contains a compound of Formula (I) and, optionally, a carrier or diluent therefor. The polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure. The compositions may provide for controlled release of the compound of Formula (I) and they may be used for seed treatment. A compound of Formula (I) may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound.

The composition may include one or more additives to improve the biological performance of the composition, for example by improving wetting, retention or distribution on surfaces; resistance to rain on treated surfaces; or uptake or mobility of a compound of Formula (I). Such additives include surface active agents (SFAs), spray additives based on oils, for example certain mineral oils or natural plant oils (such as soy bean and rape seed oil), and blends of these with other bio-enhancing adjuvants (ingredients which may aid or modify the action of a compound of Formula (I)).

Wetting agents, dispersing agents and emulsifying agents may be SFAs of the cationic, anionic, amphoteric or non-ionic type.

Suitable SFAs of the cationic type include quaternary ammonium compounds (for example cetyltri methyl ammonium bromide), imidazolines and amine salts.

Suitable anionic SFAs include alkali metals salts of fatty acids, salts of aliphatic monoesters of sulphuric acid (for example sodium lauryl sulphate), salts of sulphonated aromatic compounds (for example sodium dodecylbenzenesulphonate, calcium dodecylbenzenesulphonate, butylnaphthalene sulphonate and mixtures of sodium di- /^'sopropyl- and tri-/^'sopropyl-naphthalene sulphonates), ether sulphates, alcohol ether sulphates (for example sodium laureth-3-sulphate), ether carboxylates (for example sodium laureth-3-carboxylate), phosphate esters (products from the reaction between one or more fatty alcohols and phosphoric acid (predominately mono-esters) or phosphorus pentoxide (predominately di-esters), for example the reaction between lauryl alcohol and tetraphosphoric acid; additionally these products may be ethoxylated), sulphosuccinamates, paraffin or define sulphonates, taurates and lignosulphonates.

Suitable SFAs of the amphoteric type include betaines, propionates and glycinates.

Suitable SFAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); and lecithins.

Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).

The composition of the present may further comprise at least one additional pesticide. For example, the compounds according to the invention can also be used in combination with other herbicides or plant growth regulators. In a preferred embodiment the additional pesticide is a herbicide and/or herbicide safener. Examples of such mixtures are (in which T represents a compound of Formula (I)). I + acetochlor, I + acifluorfen, I + acifluorfen-sodium, I + aclonifen, I + acrolein, I + alachlor, I + alloxydim, I + ametryn, I + amicarbazone, I + amidosulfuron, I + aminopyralid, I + amitrole, I + anilofos, I + asulam, I + atrazine, I + azafenidin, I + azimsulfuron, I + BCPC, I + beflubutamid, I + benazolin, I + bencarbazone, I + benfluralin, I + benfuresate, I + bensulfuron, I + bensulfuron-methyl, I + bensulide, I + bentazone, I + benzfendizone, I + benzobicyclon, I + benzofenap, I + bicyclopyrone, I + bifenox, I + bilanafos, I + bispyribac, I + bispyribac-sodium, I + borax, I + bromacil, I + bromobutide, I + bromoxynil, I + butachlor, I + butamifos, I + butralin, I + butroxydim, I + butylate, I + cacodylic acid, I + calcium chlorate, I + cafenstrole, I + carbetamide, I + carfentrazone, I + carfentrazone-ethyl, I + chlorflurenol, I + chlorflurenol-methyl, I + chloridazon, I + chlorimuron, I + chlorimuron-ethyl, I + chloroacetic acid, I + chlorotoluron, I + chlorpropham, I + chlorsulfuron, I + chlorthal, I + chlorthal-dimethyl, I + cinidon-ethyl, I + cinmethylin, I + cinosulfuron, I + cisanilide, I + clethodim, I + clodinafop, I + clodinafop- propargyl, I + clomazone, I + clomeprop, I + clopyralid, I + cloransulam, I + cloransulam- methyl, I + cyanazine, I + cycloate, I + cyclosulfamuron, I + cycloxydim, I + cyhalofop, I + cyhalofop-butyl,, I + 2,4-D, I + daimuron, I + dalapon, I + dazomet, I + 2,4-DB, I + I + desmedipham, I + dicamba, I + dichlobenil, I + dichlorprop, I + dichlorprop-P, I + diclofop, I + diclofop-methyl, I + diclosulam, I + difenzoquat, I + difenzoquat metilsulfate, I + diflufenican, I + diflufenzopyr, I + dimefuron, I + dimepiperate, I + dimethachlor, I + dimethametryn, I + dimethenamid, I + dimethenamid-P, I + dimethipin, I + dimethylarsinic acid, I + dinitramine, I + dinoterb, I + diphenamid, I + dipropetryn, I + diquat, I + diquat dibromide, I + dithiopyr, I + diuron, I + endothal, I + EPTC, I + esprocarb, I + ethalfluralin, I + ethametsulfuron, I + ethametsulfuron-methyl, I + ethephon, I + ethofumesate, I + ethoxyfen, I + ethoxysulfuron, I + etobenzanid, I + fenoxaprop-P, I + fenoxaprop-P-ethyl, I + fentrazamide, I + ferrous sulfate, I + flamprop- M, I + flazasulfuron, I + florasulam, I + fluazifop, I + fluazifop-butyl, I + fluazifop-P, I + fluazifop-P-butyl, I + fluazolate, I + flucarbazone, I + flucarbazone-sodium, I + flucetosulfuron, I + fluchloralin, I + flufenacet, I + flufenpyr, I + flufenpyr-ethyl, I + flumetralin, I + flumetsulam, I + flumiclorac, I + flumiclorac-pentyl, I + flumioxazin, I + flumipropin, I + fluometuron, I + fluoroglycofen, I + fluoroglycofen-ethyl, I + fluoxaprop, I + flupoxam, I + flupropacil, I + flupropanate, I + flupyrsulfuron, I + flupyrsulfuron-methyl- sodium, I + flurenol, I + fluridone, I + flurochloridone, I + fluroxypyr, I + flurtamone, I + fluthiacet, I + fluthiacet-methyl, I + fomesafen, I + foramsulfuron, I + fosamine, I + glufosinate, I + glufosinate-ammonium, I + glyphosate, I + halauxifen, I + halosulfuron, I + halosulfuron-methyl, I + haloxyfop, I + haloxyfop-P, I + hexazinone, I + imazamethabenz, I + imazamethabenz-methyl, I + imazamox, I + imazapic, I + imazapyr, I + imazaquin, I + imazethapyr, I + imazosulfuron, I + indanofan, I + indaziflam, I + iodomethane, I + iodosulfuron, I + iodosulfuron-methyl-sodium, I + ioxynil, I + isoproturon, I + isouron, I + isoxaben, I + isoxachlortole, I + isoxaflutole, I + isoxapyrifop, I + karbutilate, I + lactofen, I + lenacil, I + linuron, I + mecoprop, I + mecoprop-P, I + mefenacet, I + mefluidide, I + mesosulfuron, I + mesosulfuron-methyl, I + mesotrione, I + metam, I + metamifop, I + metamitron, I + metazachlor, I + methabenzthiazuron, I + methazole, I + methylarsonic acid, I + methyldymron, I + methyl isothiocyanate, I + metolachlor, I + S-metolachlor, I + metosulam, I + metoxuron, I + metribuzin, I + metsulfuron, I + metsulfuron-methyl, I + molinate, I + monolinuron, I + naproanilide, I + napropamide, I + naptalam, I + neburon, I + nicosulfuron, I + n-methyl glyphosate, I + nonanoic acid, I + norflurazon, I + oleic acid (fatty acids), I + orbencarb, I + orthosulfamuron, I + oryzalin, I + oxadiargyl, I + oxadiazon, I + oxasulfuron, I + oxaziclomefone, I + oxyfluorfen, I + paraquat, I + paraquat dichloride, I + pebulate, I + pendimethalin, I + penoxsulam, I + pentachlorophenol, I + pentanochlor, I + pentoxazone, I + pethoxamid, I + phenmedipham, I + picloram, I + picolinafen, I + pinoxaden, I + piperophos, I + pretilachlor, I + primisulfuron, I + primisulfuron-methyl, I + prodiamine, I + profoxydim, I + prohexadione-calcium, I + prometon, I + prometryn, I + propachlor, I + propanil, I + propaquizafop, I + propazine, I + propham, I + propisochlor, I + propoxycarbazone, I + propoxycarbazone-sodium, I + propyzamide, I + prosulfocarb, I + prosulfuron, I + pyraclonil, I + pyraflufen, I + pyraflufen-ethyl, I + pyrasulfotole, I + pyrazolynate, I + pyrazosulfuron, I + pyrazosulfuron-ethyl, I + pyrazoxyfen, I + pyribenzoxim, I + pyributicarb, I + pyridafol, I + pyridate, I + pyriftalid, I + pyriminobac, I + pyriminobac-methyl, I + pyrimisulfan, I + pyrithiobac, I + pyrithiobac-sodium, I + pyroxasulfone, I + pyroxsulam, I + quinclorac, I + quinmerac, I + quinoclamine, I + quizalofop, I + quizalofop-P, I + rimsulfuron, I + saflufenacil, I + sethoxydim, I + siduron, I + simazine, I + simetryn, I + sodium chlorate, I + sulcotrione, I + sulfentrazone, I + sulfometuron, I + sulfometuron-methyl, I + sulfosate, I + sulfosulfuron, I + sulfuric acid, I + tebuthiuron, I + tefuryltrione, I + tembotrione, I + tepraloxydim, I + terbacil, I + terbumeton, I + terbuthylazine, I + terbutryn, I + thenylchlor, I + thiazopyr, I + thifensulfuron, I + thiencarbazone, I + thifensulfuron-methyl, I + thiobencarb, I + topramezone, I + tralkoxydim, I + tri-allate, I + triasulfuron, I + triaziflam, I + tribenuron, I + tribenuron-methyl, I + triclopyr, I + trietazine, I + trifloxysulfuron, I + trifloxysulfuron- sodium, I + trifluralin, I + triflusulfuron, I + triflusulfuron-methyl, I + trihydroxytriazine, I + trinexapac-ethyl, I + tritosulfuron, I + [3-[2-chloro-4-fluoro-5-(1 -methyl-6-trifluoromethyl- 2,4-dioxo-1 ,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetic acid ethyl ester (CAS RN 353292-31 -6). The compounds of the present invention may also be combined with herbicidal compounds disclosed in WO06/024820 and/or WO07/096576.

The mixing partners of the compound of Formula (I) may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, Fourteenth Edition, British Crop Protection Council, 2006.

The compound of Formula (I) can also be used in mixtures with other agrochemicals such as fungicides, nematicides or insecticides, examples of which are given in The Pesticide Manual.

The mixing ratio of the compound of Formula (I) to the mixing partner is preferably from 1 : 100 to 1000:1 .

The mixtures can advantageously be used in the above-mentioned formulations (in which case "active ingredient" relates to the respective mixture of compound of Formula I with the mixing partner).

The compounds of Formula (I) according to the invention can also be used in combination with one or more safeners. Likewise, mixtures of a compound of Formula I according to the invention with one or more further herbicides can also be used in combination with one or more safeners. The safeners can be AD 67 (MON 4660), benoxacor, cloquintocet-mexyl, cyprosulfamide (CAS RN 221667-31 -8), dichlormid, fenchlorazole-ethyl, fenclorim, fluxofenim, furilazole and the corresponding R isomer, isoxadifen-ethyl, mefenpyr-diethyl, oxabetrinil, N-isopropyl-4-(2-methoxy- benzoylsulfamoyl)-benzamide (CAS RN 221668-34-4). Other possibilities include safener compounds disclosed in, for example, EP0365484 e.g N-(2-methoxybenzoyl)-4- [(methylaminocarbonyl)amino]benzenesulfonamide. Particularly preferred are mixtures of a compound of Formula I with cyprosulfamide, isoxadifen-ethyl, cloquintocet-mexyl and/or N-(2-methoxybenzoyl)-4-[(methyl-aminocarbonyl)amino]benzenesulfonamide.

The safeners of the compound of Formula I may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, 14^th Edition (BCPC), 2006. The reference to cloquintocet-mexyl also applies to a lithium, sodium, potassium, calcium, magnesium, aluminium, iron, ammonium, quaternary ammonium, sulfonium or phos- phonium salt thereof as disclosed in WO 02/34048, and the reference to fenchlorazole- ethyl also applies to fenchlorazole, etc.

Preferably the mixing ratio of compound of Formula (I) to safener is from 100:1 to 1 :10, especially from 20:1 to 1 :1 .

The mixtures can advantageously be used in the above-mentioned formulations (in which case "active ingredient" relates to the respective mixture of compound of Formula I with the safener).

The present invention still further provides a method of selectively controlling weeds at a locus comprising crop plants and weeds, wherein the method comprises application to the locus of a weed controlling amount of a composition according to the present invention. 'Controlling' means killing, reducing or retarding growth or preventing or reducing germination. Generally the plants to be controlled are unwanted plants (weeds). 'Locus' means the area in which the plants are growing or will grow.

The rates of application of compounds of Formula (I) may vary within wide limits and depend on the nature of the soil, the method of application (pre- or post-emergence; seed dressing; application to the seed furrow; no tillage application etc.), the crop plant, the weed(s) to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop. The compounds of Formula I according to the invention are generally applied at a rate of from 10 to 2000 g/ha, especially from 50 to 1000 g/ha.

The application is generally made by spraying the composition, typically by tractor mounted sprayer for large areas, but other methods such as dusting (for powders), drip or drench can also be used.

Useful plants in which the composition according to the invention can be used include crops such as cereals, for example barley and wheat, cotton, oilseed rape, sunflower, maize, rice, soybeans, sugar beet, sugar cane and turf.

Crop plants can also include trees, such as fruit trees, palm trees, coconut trees or other nuts. Also included are vines such as grapes, fruit bushes, fruit plants and vegetables. Crops are to be understood as also including those crops which have been rendered tolerant to herbicides or classes of herbicides (e.g. ALS-, GS-, EPSPS-, PPO-, ACCase- and HPPD-inhibitors) by conventional methods of breeding or by genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® summer rape (canola). Examples of crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®. In a particularly preferred aspect, the crop plant has been engineered to over-express homogentisate solanesyltransferase as taught in, for example, WO2010/02931 1 .

Crops are also to be understood as being those which have been rendered resistant to harmful insects by genetic engineering methods, for example Bt maize (resistant to European corn borer), Bt cotton (resistant to cotton boll weevil) and also Bt potatoes (resistant to Colorado beetle). Examples of Bt maize are the Bt 176 maize hybrids of NK® (Syngenta Seeds). The Bt toxin is a protein that is formed naturally by Bacillus thuringiensis soil bacteria. Examples of toxins, or transgenic plants able to synthesise such toxins, are described in EP-A-451 878, EP-A-374 753, WO 93/07278, WO 95/34656, WO 03/052073 and EP-A-427 529. Examples of transgenic plants comprising one or more genes that code for an insecticidal resistance and express one or more toxins are KnockOut® (maize), Yield Gard® (maize), NuCOTIN33B® (cotton), Bollgard® (cotton), NewLeaf® (potatoes), NatureGard® and Protexcta®. Plant crops or seed material thereof can be both resistant to herbicides and, at the same time, resistant to insect feeding ("stacked" transgenic events). For example, seed can have the ability to express an insecticidal Cry3 protein while at the same time being tolerant to glyphosate.

Crops are also to be understood to include those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavour).

Other useful plants include turf grass for example in golf-courses, lawns, parks and roadsides, or grown commercially for sod, and ornamental plants such as flowers or bushes.

The compositions can be used to control unwanted plants (collectively, 'weeds'). The weeds to be controlled inlcude both monocotyledonous species, for example Agrostis, Alopecurus, Avena, Brachiaria, Bromus, Cenchrus, Cyperus, Digitaria, Echinochloa, Eleusine, Lolium, Monochoria, Rottboellia, Sagittaria, Scirpus, Setaria and Sorghum, and dicotyledonous species, for example Abutilon, Amaranthus, Ambrosia, Chenopodium, Chrysanthemum, Conyza, Galium, Ipomoea, Nasturtium, Sida, Sinapis, Solarium, Stellaria, Veronica, Viola and Xanthium. Weeds can also include plants which may be considered crop plants but which are growing outside a crop area ('escapes'), or which grow from seed left over from a previous planting of a different crop (Volunteers'). Such volunteers or escapes may be tolerant to certain other herbicides.

Various aspects and embodiments of the present invention will now be illustrated in more detail by way of example. It will be appreciated that modification of detail may be made without departing from the scope of the invention.

PREPARATION EXAMPLES

Example 1 Preparation of 4-(2-benzyloxy-3,6-dichloro-phenyl)-2,6-dimethyl- ridazine-3,5-dione

1.1 2-Allyl-3,6-dichloro-phenol

A mixture of 2-allyloxy-1 ,4-dichloro-benzene (1 .0 g, 4.9 mmol, 1.0 eq.) and DMF (0.1 mL) was heated at an external temperature of 220 °C for 1 hour. The mixture was allowed to cool to room temperature and was concentrated in vacuo to provide 2-allyl- 3,6-dichloro- henol as a brown oil (0.99 g, 99%).

¹H NMR (400 MHz, CDCI₃): δ_Η: 7.18-7.08 (1 H, m) 6.95-6.85 (1 H, m)

6.02-5.84 (1 H, m) 5.71 (1 H, s) 5.14-4.99 (2H, m) 3.59 (2H, dt).

1.2 2-Allyl-3-benzyloxy-1 ,4-dichloro-benzene

Benzyl bromide (3.2 mL, 27 mmol, 1.1 eq.) was added to a suspension of 2-allyl- 3,6-dichloro-phenol (5.0 g, 25 mmol, 1.0 eq.) and potassium carbonate (3.7 g, 27 mmol, 1 .1 eq.) in acetone (49 mL) and the mixture was heated at reflux for 6 hours. The mixture was allowed to cool to room temperature and was filtered. The filtrate was concentrated in vacuo and the crude product was purified by flash column chromatography to provide 2-allyl-3-benzyloxy-1 ,4-dichloro-benzene (4.031 g, 56%) as a colourless oil.

¹H NMR (400 MHz, CDCI₃): δ_Η: 7.54-7.49 (2H, m), 7.45-7.35 (3H, m), 7.27-7.24 (1 H, m), 7.15 (1 H, d), 6.01 -5.90 (1 H, m), 5.10-4.97 (4H, m), 3.59 (2H, dt).

1.3 2-(2-Benzyloxy-3,6-dichloro-phenyl)acetic acid

A solution of 2-allyl-3-benzyloxy-1 ,4-dichloro-benzene (38.1 g, 130 mmol, 1.00 eq.) in dichloromethane (650 mL) in a 3-necked flask was cooled to -78 °C. One side neck was connected to a Dreshel bottle containing an aqueous solution of Kl (100 mL, 15% w/w). Ozone was bubbled through the solution until 2-allyl-3-benzyloxy-1 ,4- dichloro-benzene had been fully consumed (4 hours). Air was bubbled through the solution for 10 minutes to remove excess ozone. The bubbling of gas through the solution was stopped and dimethyl sulfide (95.4 mL, 1300 mmol, 10.0 eq.) was added. The mixture was allowed to warm to room temperature and was stirred for 12 hours. The mixture was washed with brine (2 x 200 mL) and the organic extracts were passed through a hydrophobic frit. The mixture was concentrated in vacuo to provide a yellow oil (43 g). The residue was dissolved in a mixture of in ie f-butanol (260 mL) and water (130 mL) then cooled to 0 °C. 2-methylbut-2-ene (135 mL, 1300 mmol, 10.0 eq.), sodium dihydrogen phosphate (62.4 g, 520 mmol, 4.00 eq.) and sodium chlorite (44.1 g, 390 mmol, 3.00 eq.) were added. The mixture was stirred for 2 hours then diluted with brine (300 mL) and 2.0M hydrochloric acid (300 mL). The mixture was extracted with EtOAc (3 x 200 mL). The combined organic extracts were washed with a saturated aqueous solution of sodium metabisulfite (200 mL) then passed through a hydrophobic frit and concentrated in vacuo to provide a pale yellow solid (41.4 g). The residue was suspended in H₂0 (200 mL) and an aqueous solution of NaOH (30 mL, 2.0 M) was added resulting in a clear solution. The mixture was washed with Et₂0 (100 mL) and the aqueous layer was acidified by addition of concentrated HCI (20 mL) resulting in the formation of a precipitate. The mixture was filtered and the filtrand was dried in vacuo to provide 2-(2-benzyloxy-3,6-dichloro-phenyl)acetic acid (29.2 g, 72%) as a white solid.

¹H NMR (400 MHz, CDCI₃): δ_Η: 7.48-7.44 (2H, m), 7.42- 7.31 (4H, m), 7.17 (1 H, d), 5.04 (2H, s), 3.85 (2H, s). 1.4 ethyl (2E/Z)-2-(methylhydrazono)propanoate

A 3-necked 500 mL flask equipped with a stirrer bar, dropping funnel and thermometer was placed under N₂ atmosphere. Chloroform (60 mL), ethyl 2- oxopropanoate (12.9 g, 1 1 1 mmol) and magnesium sulfate (13.3 g, 1 1 1 mmol) were charged to the vessel with stirring. The resulting slurry was cooled to 0 °C (ice bath). The dropping funnel was then charged with chloroform (20 mL) and methylhydrazine (5.00 g, 109 mmol). The methylhydrazine solution was then added dropwise to the stirred reaction mixture, setting the rate of addition to maintain the temperature < 10 °C. After the addition was complete, the reaction was warmed to ambient temperature and then stirred for a further 16 h.

The reaction was filtered, washing with chloroform. The filtrate was concentrated under reduced pressure to give the desired hydrazone ethyl-2- (methylhydrazono)propanoate (15.1 g, 105 mmol, 96.5% Yield), a yellow oil, as a mixture of E/Z isomers.

¹H NMR data for major isomer: (400 MHz, CDCI₃): δ_Η: 5.58 (1 H, brs), 4.30 (2H, q), 3.24 (3H, s), 1 .92 (3H, s), 1.34 (3H, t).

1.5 ethyl 2-[[2-(2-benzyloxy-3,6-dichloro-phenyl)acetyl]-methyl-hydrazono] pro- panoate

2-(2-benzyloxy-3,6-dichloro-phenyl)acetic acid (1 .32 mmol, 0.41 g) was dissolved in dichloromethane (10 mL) under N₂ with stirring. Oxalyl chloride (3.95 mmol, 0.50 g, 0.34 mL) was added. After 2 min, /V,/V-dimethylformamide (0.13 mmol, 0.01 mL) was added dropwise. Effervescence was observed. After 1 h stirring at ambient temperature, LC/MS analysis of an aliquot quenched into MeOH showed complete conversion of acid starting material to the methyl ester (evidencing acyl chloride formation).

The reaction mixture was concentrated in vacuo to afford an orange gum.

The crude acid chloride was then redissolved in dichloromethane (10 mL) under N₂ atmosphere and cooled to 0 °C. Ethyl 2-(methylhydrazono)propanoate (1.34 mmol, 0.194 g) was added with stirring. Triethylamine (2.64 mmol, 0.37 mL) in dichloromethane (0.5 mL) was added dropwise over 10 min. The reaction mixture was stirred at 0 °C for a further 15 min, before being warmed to ambient temperature and continued a further 4 h.

The solvent was evaporated in vacuo and the residue redissolved in ethyl acetate (30 mL). Organics were washed with dilute aq. HCI solution (2 x 10 mL), saturated aq. NaHC0₃ solution (2 x 10 mL) and brine (2 x 10 mL), before being passed through a phase separator cartridge and concentrated in vacuo.

Flash column chromatography (silica, eluant a 0-5 % ethyl acetate in hexane gradient) afforded the desired product ethyl 2-[[2-(2-benzyloxy-3,6-dichloro- phenyl)acetyl]-methyl-hydrazono]propanoate (0.21 g, 36.5 %) as a yellow gum.

7.1 1 (1 H, m), 5.05-4.97 (2H, m), 4.31 (2H, q), 4.20 (2H, s), 3.31 (3H, s), 2.21 (3H, s), 1 .34 (3H, t).

1.6 4-(2-benzyloxy-3,6-dichloro-phenyl)-2,6-dimethyl-pyridazine-3,5-dione

A microwave vial was charged with ethyl 2-[[2-(2-benzyloxy-3,6-dichloro- phenyl)acetyl]-methyl-hydrazono]propanoate (0.46 mmol, 0.20 g), acetonitrile (4 mL) and 1 ,8-Diazabicyclo[5.4.0]undec-7-ene (0.98 mmol, 0.15 g, 0.15 mL). The mixture was heated under microwave irradiation at 125 °C for 50 min before LC/MS analysis showed complete reaction. The reaction mixture was diluted with ethyl acetate (20 mL) and water (10 mL) and acidified to pH 4-5 with dilute hydrochloric acid. The organics were separated and further washed with saturated aqueous ammonium chloride solution (2 x 10 mL) then brine (10 mL). The organics were then passed through a phase separator cartridge and concentrated in vacuo to afford a crude yellow gum. Flash column chromatography (silica, eluant 0-25 % ethyl acetate in hexane gradient) afforded the desired product 4-(2-benzyloxy-3,6-dichloro-phenyl)-2,6-dimethyl-pyridazine-3,5-dione (0.1 1 g, 61 %) as a pale yellow gum.

¹H NMR (400 MHz, CDCI₃): δ_Η: 2.22 (3H, s), 3.66 (3H, s), 4.70 (1 H, d), 5.08 (1 H, d), 7.13-7.17 (2H, m), 7.24-7.30 (4H, m), 7.41 (1 H, d).

BIOLOGICAL EXAMPLES

B1 Post-emergence efficacy

Seeds of a variety of test species are sown in standard soil in pots:- Solanum nigrum (SOLNI), Amaranthus retoflexus (AMARE), Setaria faberi (SETFA), Alopecurus myosuroides (ALOMY), Echinochloa crus-galli (ECHCG), Ipomoea hederacea (IPOHE), Lolium perenne (LOLPE). After 8 days cultivation (post-emergence) under controlled conditions in a glasshouse (at 24/16°C, day/night; 14 hours light; 65% humidity), the plants are sprayed with an aqueous spray solution derived from the formulation of the technical active ingredient in acetone/water (50:50) solution containing 0.5% Tween 20 (polyoxyethelyene sorbitan monolaurate, CAS RN 9005-64-5). Compounds are applied at 1000 g/ha. The test plants are then grown in a glasshouse under controlled conditions in a glasshouse (at 24/16°C, day/night; 14 hours light; 65 % humidity) and watered twice daily. After 13 days, the test is evaluated for the percentage damage caused to the plant. The biological activities are assessed on a five point scale (5 = 80- 100%; 4 = 60-79%; 3=40-59%; 2=20-39%; 7=0-19%). A blank value in the table is indicative that the compound was not tested on that species.

Table 2 Control of weed species by compounds of formula (I) after post-emergence application at a rate of

1000g/Ha

Compound LOLPE SOLNI AMARE SETFA ALOMY ECHCG IPOHE

1.001

1.002

1.003

1.004

1.005

1.006

1.007

1.009 Compound LOLPE SOLNI AMARE SETFA ALOMY ECHCG IPOHE

1.010 4 5 5 3 4 5

1.012 5 5 5 5 5 5

1.014 3 5 4 5 4 5

1.016 4 5 5 5 5 5

1.037 5 5 5 4 5 5

1.041 4 5 5 5 5 5

1.044 5 5 5 5 5 5

1.067 5 5 2 5 5 5

1.068 2 5 3 4 4 4

1.069 3 5 3 5 5 5

1.070 5 5 5 5 5 5

1.071 3 5 3 5 4 5

1.072 2 5 2 5 4 5

1.073 3 5 3 5 5 5

1.074 5 5 5 5 5 5

1.075 4 5 4 5 5 5

1.076 4 5 2 5 5 5

1.077 5 5 5 5 5 5

1.078 1 5 3 3 2 4

1.079 1 5 1 1 1 5

1.080 2 5 2 1 1 5

1.081 2 5 3 4 2 4

1.082 1 5 1 2 1 3

1.083 2 5 1 3 1 5

1.084 4 5 3 2 1 5

1.085 5 5 5 3 4 5

1.086 4 5 3 4 2 5

1.087 5 5 5 5 5 5

Claims

1. A compound of formula (I)

(I), or a salt or N-oxide thereof,

R¹ is selected from the group consisting of Ci-C₄ alkyl, C₃-C₆cycloalkyl, C₃- C₆alkoxy, Ci-C₂ alkoxy-CrC₂ alkyl, C₂-C₄ alkenyl, C C₄ haloalkyl, cyano-d- C₄alkyl, C₂-C₄ haloalkenyl, C₂-C₄ alkynyl and C₂-C₄ haloalkynyl; R² is selected from the group consisting of hydrogen, halogen, cyano, CrC₆alkyl,

CrC₆haloalkyl, CrC₆haloalkoxy, Ci-C₃haloalkoxy-Ci-C₃alkyl-, CrC₆alkoxy, C C₃alkoxy-CrC₃alkyl, Ci-C₃alkoxy-Ci-C₃alkoxy-CrC₃alkyl-, C₃-C₆cycloalkyl, C₂-C₆ alkenyl, C₂-C₆ haloalkenyl, C₂-C₆ alkynyl, CrC₆hydroxyalkyl-, CrC₆alkylcarbonyl-, Ci-C₆alkyl-S(0)_m-, amino, Ci-C₆alkylamino, Ci-C₆dialkylamino, -C(Ci-C₃alkyl)=N- 0-Ci-C₃alkyl and C₂-C₆ haloalkynyl;

G is hydrogen, or C(0)R³;

X and Y are each independently hydrogen, C C₃ alkyl, C C₃ alkoxy, C

C₃haloalkyl, Ci-C₃haloalkoxy, or halogen; Z is Ci-C₃ alkyl, C C₃ alkoxy, Ci-C₃haloalkyl, Ci-C₃haloalkoxy, or halogen; m is an integer of 0, 1 , or 2; n is an integer of 0, 1 , 2, 3, 4, or 5; R³ is selected from the group consisting of CrC₆alkyl, CrC₆alkoxy, CrC₆alkenyl, CrC₆alkynyl, CrC₆alkyl-S-, -NR⁴R⁵ and phenyl optionally substituted by one or more R⁶;

R⁴ and R⁵ are independently selected from the group consisting of Ci-C₆ alkyl and Ci-C₆ alkoxy, or R⁴ and R⁵ together can form a morpolinyl ring; and,

R⁶ is selected from the group consisting of halogen, cyano, nitro, CrC₃alkyl, d- C₃haloalky, CrC₃alkoxy and CrC₃haloalkoxy.

The compound according to claim 1 , wherein G is hydrogen or C(0)R³ wherein R³ is isopropyl, t-butyl, methyl, ethyl, propargyl, methoxy, ethoxy, or ie f-butoxy.

The compound of claim 2, wherein G is hydrogen or R³ is isopropyl.

The compound of any one of the preceding claims wherein X is

hydrogen, halogen, or dhaloalkyl.

The compound of any one of the preceding claims wherein Y is hydrogen, C C₃ alkyl, Ci-C₃haloalkyl, or halogen.

The compound according to any one of the preceding claims wherein X is ortho with respect to the pyrdazinone/pyridazine-dione moiety.

The compound according to any one of the preceding claims wherein Y is ortho with respect to the benzyloxy moiety.

The compound according to any one of the preceding claims wherein R¹ is methyl, ethyl, n-propyl, cyclopropyl, propargyl, or Cihaloalkyl.

The compound according to any one of the preceding claims wherein R² is selected from the group consisting of hydrogen, CrC₆alkyl, CrC₆haloalkyl, d- C₆alkoxy, Ci-C₃alkoxy-CrC₃alkyl, C₃-C₆cycloalkyl, C₂-C₆ alkenyl, C₂-C₆ haloalkenyl, C₂-C₆ alkynyl and C₂-C₆ haloalkynyl.

10. The compound according to any one of the preceding claims wherein R² is

selected from the group consisting of, methyl, ethyl, cyclopropyl, trifluoromethyl and methoxymethyl,

1 1 . The compound according to any one of the preceding claims wherein R² is cylcopropyl or methyl 12. The compound according to any one of the preceding claims wherein n is 0, 1 , or 2.

13. The compound according to any one of the preceding claims wherein each Z is independently selected from halogen, methyl, methoxy, and trifluoromethyl.

14. A herbicidal composition comprising a herbicidal compound according to any one of claims 1 -13 and an agriculturally acceptable formulation adjuvant.

15. A herbicidal composition according to claim 14, further comprising at least one additional pesticide.

16. A herbicidal composition according to claim 15, wherein the additional pesticide is a herbicide or herbicide safener. 17. A method of controlling unwanted plant growth, comprising applying a compound of formula (I) as defined in any one of claims 1 to 13, or a herbicidal composition according to any one of claims 14 to 16, to the unwanted plants or to the locus thereof. 18. Use of a compound of Formula (I) as defined in any one of claims 1 to 13 as a herbicide.